Stocks
ImmunoGen (IMGN) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 3 315% | 4 025% | 12 496% | 15 643% | 15 643% | 12 933% | |||
| Changes by years, y/y, % | -9 207pp | +711pp | +8 471pp | +3 147pp | 0pp | +4.6% | |||
ImmunoGen. R&D/CAPEX, %
ImmunoGen. R&D/CAPEX, changes, pp
ImmunoGen (IMGN) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q1 | 2023Q4 | 2023Q2 | 2023Q3 | LTM ? | |||
| R&D/CAPEX, % | 22 761% | 24 699% | 64 201% | 64 201% | 3 513% | 12 933% | ||
| Changes by years, y/y, % | +12 930pp | +10 274pp | +40 619pp | +39 360pp | -6 317pp | |||
| Changes by quarters, q/q, % | -822pp | +1 938pp | +39 503pp | 0pp | -60 688pp | |||
